Medicare Enrolled

Dr. Jason Moche, MD

Otolaryngology · New York, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
18 E 48TH ST FL 2, New York, NY 10017
6468684300
In practice since 2007 (19 years)
NPI: 1710010103 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Moche from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Moche? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Moche

Dr. Jason Moche is an otolaryngology specialist in New York, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Moche performed 1,000 Medicare services across 742 unique beneficiaries.

Between the years covered by Open Payments, Dr. Moche received a total of $330,002 from 34 pharmaceutical and/or device companies across 514 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in otolaryngology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Moche is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 44% volume in NY $330,002 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,000
Medicare services
Top 44% in NY for otolaryngology
742
Unique beneficiaries
$103
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~53 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Nasal endoscopy
A diagnostic procedure that uses a thin, lighted tube to examine the inside of the nasal passages.
298 $170 $766
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
268 $80 $217
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
109 $98 $200
Ear wax removal
A procedure to remove impacted ear wax from the ear canal.
93 $27 $252
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
83 $113 $225
Microscopic ear examination
A detailed visual inspection of the ear using a specialized microscope to examine the ear canal and eardrum.
62 $26 $65
Flexible laryngoscopy
A diagnostic exam of the voice box using a flexible endoscope to visualize the larynx.
56 $111 $290
Impacted earwax removal by physician
Removal of impacted earwax from one or both ears by a physician on the same day as audiologic testing.
31 $34 $109
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$330,002
Total received (2018-2024)
Avg $47,143/year across 7 years
Top 0% in NY for otolaryngology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
514
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$319,432 (96.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,568 (2.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,002 (1.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$114,103
2023
$89,175
2022
$42,731
2021
$37,638
2020
$18,980
2019
$20,276
2018
$7,099

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$105,508
Regeneron Healthcare Solutions, Inc.
$8,198
Optinose US, Inc.
$132
Acclarent, Inc
$118
Phathom Pharmaceuticals, Inc.
$51
Hikma Pharmaceuticals USA
$41
LEO Pharma Inc.
$26
GlaxoSmithKline, LLC.
$14
kaleo, Inc.
$14
Top 3 companies account for 99.8% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$246,113
Regeneron Healthcare Solutions, Inc.
$41,705
Optinose US, Inc.
$18,729
OptiNose US, Inc.
$17,655
Acclarent, Inc
$1,511
Intersect ENT, Inc.
$660
Aerin Medical Inc.
$631
AstraZeneca Pharmaceuticals LP
$513
GlaxoSmithKline, LLC.
$301
AERIN MEDICAL INC.
$214
Incyte Corporation
$207
Stryker Corporation
$206
JAZZ PHARMACEUTICALS INC.
$195
SANOFI-AVENTIS U.S. LLC
$185
Genentech USA, Inc.
$146
Celgene Corporation
$140
Medical Device Business Services, Inc.
$124
ARBOR PHARMACEUTICALS, INC.
$105
Hikma Pharmaceuticals USA
$97
ALK-Abello, Inc
$93
Jazz Pharmaceuticals Inc.
$66
kaleo, Inc.
$52
Phathom Pharmaceuticals, Inc.
$51
Novartis Pharmaceuticals Corporation
$49
Resmed Corp
$28
Harmony Biosciences LLC
$28
Aimmune Therapeutics, Inc.
$27
LEO Pharma Inc.
$26
ABBVIE INC.
$25
Mylan Specialty L.P.
$24
Medtronic USA, Inc.
$24
Eyevance Pharmaceuticals LLC
$24
Shire North American Group Inc
$22
Kaleo, Inc.
$22
Top 3 companies account for 92.9% of all-time payments
Associated products mentioned in payments ›
ACCLARENT AERA EUSTACHIAN TUBE BALLOON DILATION SYSTEM · ACCLARENT Balloon Inflation Device · ACCLARENT NAVWIRE SINUS NAVIGATION GUIDEWIRE · ADBRY · AIRSENSE · AQUAMANTYS · AUDION ET DILATION SYSTEM · AUVI-Q · Acclarent Aera · Acclarent Navwire · CUVITRU · DUPIXENT · Dymista · ENTELLUS - XPRESS ENT DILATION SYSTEM · FASENRA · MATRIXMANDIBLE · NUCALA · OPZELURA · Odactra · Otezla · Otovel · PALFORZIA · PROPEL · RINVOQ · Ryaltris · SINUVA · SUNOSI · TRELEGY ELLIPTA · Tobradex ST · TruDi · TruDi NAV Cable · TruDi Navigation System · VIVAER STYLUS · VOQUEZNA · VivAer · Vivaer RF Stylus · WAKIX · XOLAIR · XYREM · XYWAV · Xhance · Xolair · Xyrem
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (97%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in otolaryngology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for otolaryngology in NY.

Looking for an otolaryngology specialist in New York?
Compare otolaryngologists in the New York area by procedure volume, costs, and industry payment transparency.
Browse otolaryngologists nearby

Geographic Context

Otolaryngologists within 10 mi
548
Per 100K population
33.7
County median income
$104,553
Nearest hospital
BELLEVUE HOSPITAL CENTER
0.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Moche is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 0% of NY peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Moche experienced with nasal endoscopy?
Based on Medicare claims data, Dr. Moche performed 298 nasal endoscopy services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Moche receive payments from pharmaceutical companies?
Yes. Dr. Moche received a total of $330,002 from 34 companies across 514 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Moche's costs compare to other otolaryngologists in New York?
Dr. Moche's average Medicare payment per service is $103. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Moche) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →